These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 9924479)

  • 21. Evaluating counseling outcome on adherence to prophylaxis and follow-up after sexual HIV-risk exposure: a randomized controlled trial.
    Bentz L; Enel P; Dunais B; Durant J; Poizot-Martin I; Tourette-Turgis C; Rebillon M; Le Duff F; Dellamonica P; Pradier C
    AIDS Care; 2010 Dec; 22(12):1509-16. PubMed ID: 20824548
    [TBL] [Abstract][Full Text] [Related]  

  • 22. CDC takes a large tiger by the tail: how to handle post-exposure treatment. Centers for Disease Control and Prevention.
    AIDS Alert; 1997 Sep; 12(9):97-100. PubMed ID: 11364588
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Post-sexual exposure prophylaxis: a roundtable discussion.
    Katz M; Gerberding J; Boswell S
    AIDS Clin Care; 1998 Feb; 10(2):9-11, 16. PubMed ID: 11365078
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Introduction of HIV post-exposure prophylaxis for sexually abused children in Malawi.
    Ellis JC; Ahmad S; Molyneux EM
    Arch Dis Child; 2005 Dec; 90(12):1297-9. PubMed ID: 16174638
    [TBL] [Abstract][Full Text] [Related]  

  • 25. HIV post-exposure prophylaxis provided at an urban paediatric emergency department to female adolescents after sexual assault.
    Merchant RC; Keshavarz R; Low C
    Emerg Med J; 2004 Jul; 21(4):449-51. PubMed ID: 15208228
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Dynamics of contracting HIV seen in its social, environmental and cultural dimension].
    Gala Gonzalez A; Berdasquera Corcho D; Pérez Avila J; Pinto Valluerca J; Suárez Valdéz J; Joanes Fiol J; Sánchez L; Aragonés López C; Díaz González M
    Rev Cubana Med Trop; 2007; 59(2):90-7. PubMed ID: 23427440
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cost-effectiveness of postexposure prophylaxis after sexual or injection-drug exposure to human immunodeficiency virus.
    Pinkerton SD; Martin JN; Roland ME; Katz MH; Coates TJ; Kahn JO
    Arch Intern Med; 2004 Jan; 164(1):46-54. PubMed ID: 14718321
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Use of HIV Postexposure Prophylaxis in healthcare workers after occupational exposure: a Thai university hospital setting.
    Kiertiburanakul S; Wannaying B; Tonsuttakul S; Kehachindawat P; Apivanich S; Somsakul S; Malathum K
    J Med Assoc Thai; 2006 Jul; 89(7):974-8. PubMed ID: 16881429
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Determinants of high-risk sexual behavior during post-exposure prophylaxis to prevent HIV infection.
    Golub SA; Rosenthal L; Cohen DE; Mayer KH
    AIDS Behav; 2008 Nov; 12(6):852-9. PubMed ID: 17682938
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Non-occupational postexposure HIV prophylaxis: clinical issues and public health questions.
    Mayer KH; Kwong J; Singal R; Boswell S
    Med Health R I; 2000 Jul; 83(7):210-3. PubMed ID: 10934823
    [No Abstract]   [Full Text] [Related]  

  • 31. Sexual risk behavior in HIV-infected injection drug users.
    Battegay M; Bucher HC; Vernazza P
    Clin Infect Dis; 2004 Apr; 38(8):1175-7. PubMed ID: 15095225
    [No Abstract]   [Full Text] [Related]  

  • 32. Post-exposure prophylaxis of HIV infection: German-Austrian recommendations.
    ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ;
    Eur J Med Res; 2002 Dec; 7(12):509-27. PubMed ID: 12539739
    [No Abstract]   [Full Text] [Related]  

  • 33. [Post-exposure prophylaxis of HIV infection. German-Austrian recommendations, update September 2007].
    ;
    Dtsch Med Wochenschr; 2009 Jan; 134 Suppl 1():S16-33. PubMed ID: 19172552
    [No Abstract]   [Full Text] [Related]  

  • 34. HIV postexposure prophylaxis: Who should get it?
    Campos-Outcalt D
    J Fam Pract; 2006 Jul; 55(7):600-4. PubMed ID: 16822447
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The uptake of HIV post-exposure prophylaxis within a sexual assault setting in Sydney, Australia.
    Templeton DJ; Davies SC; Garvin AL; Garsia RJ
    Int J STD AIDS; 2005 Feb; 16(2):108-11. PubMed ID: 15807937
    [TBL] [Abstract][Full Text] [Related]  

  • 36. What you need to know to educate patients about PEP.
    AIDS Alert; 1998 Apr; 13(4):suppl 1-2. PubMed ID: 11365145
    [TBL] [Abstract][Full Text] [Related]  

  • 37. CDC considers 'morning after' therapy for sexual exposure. Centers for Disease Control and Prevention.
    AIDS Policy Law; 1997 Jun; 12(12):4. PubMed ID: 11364408
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cost-effectiveness of HIV post-exposure prophylaxis in France.
    Herida M; Larsen C; Lot F; Laporte A; Desenclos JC; Hamers FF
    AIDS; 2006 Aug; 20(13):1753-61. PubMed ID: 16931940
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [HIV post-exposure prophylaxis after sexual risk contact].
    Battegay M; Zimmerli W
    Schweiz Med Wochenschr; 1999 Feb; 129(8):311-3. PubMed ID: 10189667
    [No Abstract]   [Full Text] [Related]  

  • 40. The effects of new treatments on sexual risk taking.
    van der Straten A
    Focus; 1998 Jul; 13(8):5-6. PubMed ID: 11365604
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.